FBXO32 and sarcopenia: Based on the observed inhibitory potency of G. uralensis against atrophy and protein degradation-related marker genes (Atrogin1 and MuRF1), we suggest that G. uralensis be considered a therapeutic agent for the prevention and treatment of muscular dystrophy, sarcopenia, and cachexia.